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Abstract
There is a considerable heterogeneity in blood cell telomere length (TL) for individuals of similar age and recent studies
have revealed that TL changes by time are dependent on TL at baseline. TL is partly inherited, but results from several
studies indicate that e.g. life style and/or environmental factors can affect TL during life. Collectively, these studies imply
that blood cell TL might fluctuate during a life time and that the actual TL at a defined time point is the result of potential
regulatory mechanism(s) and environmental factors. We analyzed relative TL (RTL) in subsequent blood samples taken six
months apart from 50 individuals and found significant associations between RTL changes and RTL at baseline. Individual
RTL changes per month were more pronounced than the changes recorded in a previously studied population analyzed
after 10 years’ follow up. The data argues for an oscillating TL pattern which levels out at longer follow up times. In a
separate group of five blood donors, a marked telomere loss was demonstrated within a six month period for one donor
where after TL was stabilized. PCR determined RTL changes were verified by Southern blotting and STELA (single telomere
elongation length analysis). The STELA demonstrated that for the donor with a marked telomere loss, the heterogeneity of
the telomere distribution decreased considerably, with a noteworthy loss of the largest telomeres. In summary, the
collected data support the concept that individual blood cell telomere length is a dynamic feature and this will be important
to recognize in future studies of human telomere biology.
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Introduction
Telomere attrition by increasing age is a characteristic feature of
peripheral blood cells as demonstrated in a large number of studies
[1–5]. Regarding determinants for telomere length (TL), heredity
is a well recognized major component [6–10] and for which the
paternal influence seems to be of most importance [11–13]. There
are also numerous studies indicating that blood cell TL is
associated to various diseases, examples of which are diabetes,
hypertension, arteriosclerosis and cancer [14–21]. In general,
short telomeres have been coupled to increased risk of several
diseases. It has been discussed whether short TL is important for
disease development, if it is a biomarker for ongoing processes
leading to disease or if the disease per se, or its treatment, can
cause increased telomere shortening. Regarding TL and cancer
risk the data is inconsistent and both short and long TL has been
coupled to increased risk [22]. It should also be noted that several
published studies have been unable to show any association
between TL and disease (as summarized in reference [23]).
Furthermore, factors like life style and stress have been indicated
to influence the blood cell TL attrition rate [24–25]. These data
are in line with the fact that the heritable impact on TL decreases
by increasing age [13], signifying the impact of micro- and/or
macro-environmental factors in determining TL. What also must
be taken into account is that blood cell TL measurements reflect
the mean TL of a number of immune cell subpopulations. The
status of the immune system, i.e. cell activity, proliferation rate,
cytokine levels etc., is not constant. Hence, changes in immune
system activity are likely to be reflected also in blood cell TL.
Most published population studies on blood cell TL are cross-
sectional and besides a gradual telomere loss by age, a consistent
finding is a large inter-individual variation. However, the variation
in individual TL is reduced in the oldest old group [26]. Recent
longitudinal studies, using different techniques for TL determina-
tion, have shown that individuals with longer telomeres at baseline
experience the largest telomere attrition rates [27–30]. These
findings might indicate an intrinsic mechanism for TL regulation
giving priority to short telomeres. Another possibility is that longer
telomeres are more susceptible than short telomeres to potential
telomere noxious factors, like oxidative stress, leading to increased
telomere attrition [31]. Altogether, the collected data indicate that
blood cell TL regulation is a complex process influenced by a
multitude of factors. We hypothesized that individual blood TL is
a dynamic parameter which during periods might undergo
considerable losses and during other periods show stability or
even be extended. We here present data that blood cell TL indeed
can change substantially within a short period of time (months)
and that these changes are larger than previously reported to occur
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cell TL is a dynamic feature.
Results
In the 6 month study, 50 individuals (15 men and 35 women),
all of similar ages and obese, were analyzed with regard to RTL
changes over time. In order to minimize the risk of methodological
errors leading to a theoretical regression to the mean phenome-
non, each sample was assayed twice with satisfactory reproduc-
ibility (inter-assay mean CV=6.0%) and mean RTL values were
used. There were no differences in baseline RTL (P=0.356) or
follow up RTL (P=0.734) comparing individuals receiving
physical activity on prescription (n=25) with those receiving
minimal intervention (n=25) (Table 1). In the former group, 13
individuals showed a stable or increased RTL and 12 individuals
demonstrated RTL shortening, as compared to 12 with stable/
increased RTL and 13 with decreased RTL in the latter group.
Since the two groups did not differ with regard to telomere length
they were fused. Hence, out of the 50 individuals analyzed, 25
showed a decrease in telomere length (‘‘RTL decreasers’’) whereas
25 demonstrated elongated/stable telomeres (‘‘RTL increasers’’).
RTL data for these individuals are given in table 1. At baseline,
RTL decreasers had significantly longer telomeres as a group
compared to the RTL increasers (P=0.010; table 1). At follow up
the opposite was found, i.e. RTL decreasers had significantly
shorter RTL compared to RTL increasers (P=0.014; table 1).
There were significant correlations between RTL changes per
month versus baseline RTL (fig. 1A) and follow up RTL (fig. 1B).
Hence, individuals with the longest RTL at baseline tended to
shorten their telomeres the most, and vice versa. No significant
correlations existed between telomere length and body mass index
(BMI), neither at baseline (r=0.062; P=0.667), nor at follow up (
r=20.099, P=0.495). Also, there were no significant differences
in BMI comparing physical activity on prescription vs. minimal
intervention groups (Baseline P=0.165; Follow up P=0.109), or
comparing RTL decreasers vs. RTL increasers (Baseline
P=0.357; Follow up P=0.308) (data not shown).
The pattern of an association between RTL changes and RTL
at baseline is in concordance with our previously published data
from the 10 year study [27]. Therefore, we reanalyzed data from
that study and calculated RTL changes per month (instead of per
year). Only individuals $60 years of age at baseline were selected
(n=31) in order to better match the ages of the 6 month study
participants. Monthly RTL changes in the 10 year study were
found to be much smaller compared to the changes in the 6 month
study. This is illustrated in figure 2A, showing data from the two
studies plotted together. At the same time, there was a significant
correlation between baseline samples and follow up samples in the
6 month study (r=0.588, P,0.001), which was not seen in the 10
year study (r=0.014, P=0.939), as demonstrated in figure 2B.
In a separate material of five blood donors, subsequent blood
samples (three samples per donor) were analyzed with regard to
RTL changes over various time spans. RTL changes for each
donor are demonstrated in figure 3, showing that for four of these
donors RTL stayed rather stable over time, with only small
fluctuations. However, one donor (Donor 5) demonstrated a large
telomere loss between the first and second sample taken 6 months
apart, where after RTL was stable for 12 additional months. The
RTL change between the first and second sample was so
noteworthy that additional, frozen samples from this donor were
thawed and tested, showing the same results. To further verify this
finding we performed Southern blotting, which demonstrated very
similar findings to the telomere-PCR data as illustrated in figure 4,
showing Donor 5 and Donor 2 (control). The result was also
verified by the STELA method, analyzing the XpYp chromosome
telomeres (fig. 5). Donor 2 was selected as a control since RTL
remained rather stable over time, and there were sufficient
amounts of DNA to perform RT-PCR, Southern Blot and
STELA. For Donor 5, the mean kbp loss between sample one and
two was estimated to be approximately 3.9 kbp over a 6 months
period (i.e. an average monthly decrease of ,0.65 kb) (fig. 5A).
The heterogeneity of the telomere distribution was also decreased
considerably, with a noteworthy loss of the largest telomeres
(fig. 5B). The longest telomere end in the first sample was 19.5 kb,
compared to at six months 9.8 kb and 10.1 kb at 18 months (a
change of 9.7 kb). To test the concordance between the telomere-
PCR and STELA method, a total of 11 DNA samples were
included in the STELA (5 DNA samples from the Blood donor
study shown in Fig. 5, plus 6 DNA samples from the 6 month
study). The two methods correlated well with each other, with an
R
2 value of 0.79 (data not shown).
Discussion
In the present study we show that the individual blood cell TL can
experience shortening as well as elongation during a rather short period
of time (months). In concordance with previously published data of
longer time spans [27–30], there was a negative correlation between
baseline RTL and RTL changes over time. As compared to our
Table 1. Relative telomere length (RTL) data for individuals included in the 6 month study (median values).
Total Minimal intervention
Physical activity on
prescription RTL decreasers RTL increasers
N 50 25 25 25 25
Baseline RTL 0.5776 0.5841 0.5726 0.6201 0.5602
P
* 0.356 0.010
Follow up RTL 0.5771 0.5777 0.5765 0.5488 0.6087
P
* 0.734 0.014
RTL change/month 20.0005 20.0014 0.0009 20.0072 0.0099
P
* 0.308 ,0.001
Note: Age of participants: 67–68 yrs; 15 men and 35 women.
*) Between group differences (physical activity on prescription vs. minimal intervention, and RTL
decreasers vs. RTL increasers) were tested by Mann-Whitney U-tests.
doi:10.1371/journal.pone.0021485.t001
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RTL changes were greater in the 6 month study. In individual cases
remarkable TL changes could be observed, best exemplified in the
present study by one of the blood donors who showed a loss of
,3.9 kbp in the mean telomere length distribution over a 6 months
period and a loss of 9.7 kb in the upper limit of telomere length. Taken
together the data show that blood cell TL in individual cases can be a
highly dynamic feature exhibiting considerable length changes over
comparatively short periods of time.
In early life there is a strong impact of inheritance on blood cell
TL [6–13]. The strength of the heredity factor appears however to
diminish by age, and we previously showed that parent-child RTL
correlations were considerably stronger at younger ages (R
2 ,50%
at parental age,50 years) compared to older ages (R
2,5% at
parental age .70 years) [13]. The vast majority of studies
investigating blood cell telomeres in various conditions or diseases
have been performed on persons older than 50 years of age. Thus,
the RTL values observed in those individuals are, most likely, only
to a minor extent an effect of heredity and rather due to a
combined effect of positive and negative mechanisms affecting
blood cell TL during life.
Oxidative stress, which experimentally can induce accelerated
telomere loss [31], is a common feature for a number of conditions
where shorter telomeres have been found in patients compared to
controls. Examples of such conditions include abnormal blood
lipid levels and diabetes but also chronic psychological stress [32–
34]. Telomere related effects of oxidative stress might be more
pronounced in tissue compartments with high cellular turnover,
such as the bone marrow. Since peripheral blood cells originate
from the bone marrow, telomere alterations in bone marrow
progenitors should be reflected also in peripheral blood cells.
Indeed, it was previously shown that the telomere length of
peripheral leukocytes correlated well with their bone marrow
precursors in patients with coronary artery disease [35]. A long-
term burden of oxidative stress, such as in chronic diseases, might
be a contributing factor for RTL alterations. Interestingly, persons
exposed to intense oxidative stress were recently shown to elongate
the telomeres in granulocytes and naı ¨ve T cells but not in memory
T and B cells. The elongation was then followed by a TL
reduction [36]. These fluctuations in TL (increases and losses)
occurred during 12 months observation and could theoretically be
explained by a ‘‘population mixture model for nonlinear telomere
dynamics’’ proposed by Itzkovitz et al [37]. These data and ours
do not disagree with the notion that ‘‘age dependent shortening is
the rule’’ as discussed by Chen et al [38], but elongated telomeres
can in fact be recorded at certain periods of a life time, and the
mechanisms behind these observations remain to be elucidated. In
the present study, RTL measurements were performed two or
three times at different occasions and the mean values were used
for further statistics, in order to avoid measurement errors as an
explanation to the data as argued by Chen et al [38]. Thus, we
believe that there is a true biological variation in blood TL. Seen
over a life time, telomere shortening will occur in each person,
although not in a linear fashion.
The status of the immune system should also affect the
estimated blood cell TL at a certain time point. For example,
there is a shift from naı ¨ve T cells toward memory T-cells with
ageing [39] and memory T cells have shorter telomeres than their
naive counterparts [40]. The ratio between e.g. granulocytes and
lymphocytes might also vary. The cellular composition of
peripheral blood at a specific time point might thus be a relevant
factor. Also, a less active immune system or a suppressed immune
system might, at least theoretically, lead to less telomere attrition
due to less cellular proliferation. In addition, molecular factors
with potential positive influences on telomere length could also be
of importance. For example, it is known that estrogen can activate
the hTERT promoter of telomerase [41] and several cytokines
have telomerase stimulatory effects [42–43]. We recently found
that serum levels of IL-6, IL-7, IL-8 and IL-10 were positively
correlated to the TL in renal cell carcinoma tumor tissue, however
not to TL in blood cells in these patients (unpublished data).
Irrespective of the biological background, leukocyte telomeres
appear to oscillate in length over time. We created a model, as shown
Figure 1. Relative telomere length (RTL) and monthly RTL
changes in the 6 month study. Baseline RTL versus RTL changes per
month, showing a significant negative correlation. Follow up RTL versus
RTL changes per month, showing a significant positive correlation.
doi:10.1371/journal.pone.0021485.g001
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which levels out at longer follow up times. Future longitudinal studies
are needed with shorter intervals between sampling in order to
substantiate the rate by which RTL changes can occur in vivo.W e
believe that the dynamic feature of leukocyte telomeres is important
to recognize in future studies of human telomere biology.
Materials and Methods
Ethics statement
This study was approved by the regional ethics committee in
Stockholm, Sweden (2006/229-31/3 and 04-520/2).
Samples investigated
The ‘‘10 year study’’. Data from a previously published,
population based longitudinal study on 959 individuals [27] were
statistically reanalyzed regarding TL changes over time. From
these individuals two blood samples had been obtained within a
time span of about 10 years, thereby giving the cohort its name
‘‘the 10 year study’’. The reanalysis was restricted to individuals
aged 60 years and older at baseline (n=31). Detailed information
regarding sampling and TL analyses are given in reference 27.
The ‘‘6 month study’’. 56 individuals, 67–68 years of age,
sedentary, overweight and with abdominal obesity were
investigated for telomere length in whole blood samples taken
Figure 2. Data comparisons between the 6 month study and the 10 year study. A. Baseline RTL versus RTL changes per month. Monthly RTL
changes were greater in the 6 month study compared to the 10 year study. B. Baseline RTL versus follow up RTL, showing a significant correlation in
the 6 month study but not in the 10 year study.
doi:10.1371/journal.pone.0021485.g002
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six-month period, half of the participants received physical activity
on prescription whereas the other half received minimal
intervention (written general information about physical activity).
In the present study TL changes during the six months period
were determined and data regarding effects of physical activity and
other parameters have been presented elsewhere [44].
The ‘‘Blood donor study’’. Three subsequent blood samples
were obtained from five blood donors at intervals ranging from 2
to 25 months. The donor group comprised one woman and four
men, with baseline ages ranging from 26 to 43 years.
Telomere length PCR
The methodology for TL determinations has been detailed
previously [11]. In short, relative telomere length (RTL) was
measured using quantitative real-time PCR and calculated by the
DDCt method. Telomere and b-globin primer sequences written







All samples were loaded as triplicates. Telomere/single copy gene
(T/S) values were calculated by 2
-DCt and relative T/S values (i.e.
RTL values) were generated by dividing sample T/S values with the
T/S value of a reference cell line DNA (CCRF-CEM), included in
each plate. To monitor the PCRefficiency (E), all plates also included
a standard curve. The efficiency of an RT-PCR reaction can be
calculated by using the formula E=10
[21/slope] 21. Ideally the
efficiency equals 100%. The mean (+/2 SEM) slope-values for the
telomereand HBG assays in the current study were 23.52 (+/20.02)
and 23.11 (+/20.03) respectively, generating efficiencies of ,92%
(telomere assay) and 109% (HBG assay), which is within the
recommended range [45].
In the 6 month study, a total of 112 blood samples (56
individuals, two samples per person) were analyzed. Until DNA
extraction, whole blood cells were frozen and kept at 270uC.
DNA extraction was performed using the BioRobot M48
Workstation with MagAttract technology as described elsewhere
(Qiagen, Germany). For each DNA sample, telomere length was
measured twice at different occasions. The mean inter-assay
coefficient of variation (CV) for these samples was 6.7%. Six
samples had a CV.15% and were excluded from further analysis.
The mean CV for the remaining samples was 6.0%. Thus, TL
changes were evaluated for 50 individuals. The RTL value given
for each sample is the mean value of the separated PCR
amplifications.
In the Blood donor study, buffy coats were separated by density
gravity centrifugation (Ficoll-Hypaque; GE Healthcare). PBMC
were cryopreserved in liquid nitrogen in 10% DMSO and 90%
heat-inactivated FBS for later usage. Each sample was analyzed at
three separate occasions (mean inter-assay CV=5.3%). Other-
wise, the PCR analysis was performed as described above.
Southern blotting
Six DNA samples from the Blood donor study were selected for
the Southern blot analysis [three from Donor 2 (control) and three
from Donor 5)]. 5.5 mg DNA was cut over night at 37uC with Hinf
Figure 3. RTL values of subsequent blood samples obtained
from five blood donors. Donor 5 demonstrated a marked change
(decrease) in RTL between the first and second blood draw, which was
not seen in any other donor.
doi:10.1371/journal.pone.0021485.g003
Figure 4. Telomere length distributions (blood donor 5 and 2)
analyzed by Southern blot. The Southern blot analysis verified the
RT-PCR results, showing a marked telomere length shortening for donor
5 during a six-month period. Donor 2 was used as a control.
doi:10.1371/journal.pone.0021485.g004
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40 hours. The DNA was transferred to a Hybond- XL membrane
(GE Healthcare/Amersham Biosciences, Sweden) and the mem-
brane was air dried and UV cross linked. The membrane was
prehybridized for 15 minutes at 45uC in QuikHyb solution
(Stratagene, USA). A mixture of
32P-end labeled (T2AG3)4-probe
(minimum 2,5610
6 cpm/2 ml QuickHyb solution) and salmon
sperm DNA (1 mg) was added to the QuikHyb solution and
hybridized to the DNA at 45uC for one hour. The membrane was
washed 2615 min in 2X SSC +0,1% SDS in room temperature
and for 30 min at 45uC in 0,1X SSC +0,1% SDS. The membrane
was covered with plastic and exposed to a phosphor screen over
night or up to 4 days. The screen was scanned in a Typhoon 9400
imager (GE Healthcare/Amersham Biosciences, Sweden).
Single telomere length analysis (STELA)
Six DNA samples were selected from the 6 month study (three
baseline samples and three matched follow up samples) and five
DNA samples from the Blood donor study (two from Donor 2
(control) and three from Donor 5), based on data from the PCR
based RTL measurements. For TL analyses at the XpYp
telomeres, we used a modification of the STELA assay previously
described [46–47]. Briefly genomic DNA was solubilised by
digestion with EcoRI, quantified by Hoechst 33258 fluorometry
(BioRad, Hercules, USA) and diluted to 10 ng/ml in 10 mM Tris-
HCl pH 7.5. 10 ng of DNA was further diluted to 250 pg/mli na
volume of 40 ml containing 1 mM Telorette2 linker and 1 mM
Tris-HCl pH 7.5. Multiple PCRs (6 reactions per sample) were
carried out for each test DNA in 10 ml volumes 250 pg of DNA,
0.5 mM of the telomere-adjacent and Teltail primers, 75 mM Tris-
HCl pH8.8, 20 mM (NH4)2SO4, 0.01% Tween-20, 1.5 mM
MgCl2, and 0.5 U of a 10:1 mixture of Taq (ABGene, Epsom,
UK) and Pwo polymerase (Roche Molecular Biochemicals, Lewes,
UK). The reactions were cycled with an MJ PTC-225 thermo-
cycler (MJ research, Watertown, USA). The DNA fragments were
resolved by 0.5% TAE agarose gel electrophoresis, and detected
by two separate Southern hybridisations with random-primed
a-
33P labelled (Amersham Biosciences, Little Chalfont, UK)
TTAGGG repeat probe and a telomere-adjacent probe, together
with a probe to detect the 1 kb (Stratagene, La Jolla, USA) and
2.5 kb (BioRad) molecular weight marker. The hybridised
fragments were detected by phosphorimaging with a Molecular
Dynamics Storm 860 phosphorimager (Amersham Biosciences,
Little Chalfont, UK). The molecular weights of the DNA
fragments were calculated using the Phoretix 1D quantifier
(Nonlinear Dynamics, Newcastle-upon-Tyne, UK).
Figure 5. XpYp telomere end distributions in single telomere
length analysis (STELA) (6 lanes/sample). A. Comparison between
blood donors 5 and 2 (control), showing similar patterns as the results
from RT-PCR and Southern blot. The 3 month data for Donor 2 could
not be included in the STELA, due to a lack of DNA after the Southern
blot analysis. B. The telomere distribution in the samples from Donor 5,
showing a considerable decrease in heterogeneity and a loss of the
largest telomeres.
doi:10.1371/journal.pone.0021485.g005
Figure 6. The oscillation hypothesis. Hypothetical illustration of
RTL changes over time at the individual (solid line) and population
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PASW Statistics 18.0 (SPSS Statistics) was used for statistical
evaluation. Monthly RTL changes were calculated by dividing
delta RTL (i.e. follow up RTL – baseline RTL) with the number of
months between the dates of sample collections. Between-group
differences were tested with Mann-Whitney U tests. Correlation
analyses between baseline RTL, follow up RTL and RTL changes
(per month) were performed using Spearman’s correlation
analyses. Included in the statistical evaluation were 50 individuals
from the 6 month study, 31 individuals from the 10 year study,
and 5 individuals making up the Blood donor study.
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